Buradasınız

Anasayfa » Content

Behçet hastalığı: klinik bulgular ve tedavi

Behçet's disease : clinical features and treatment

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 1995

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Behçet disease which is characterized by a relapsing inflammatory process of unknown etiology presents several clinical manifestations involving many organ sy stems. Because of the multisystem nature of the disease different treatment modalities have been advocated and many others are still under investigation In this article, the clinical manifestations, diagnostic criteria and recent advances in the treatment of Behcet's disease are reviewed. (Journal of Turgut (hal Medical ('enter 2(1): "H-H5.1995 j
Bookmark/Search this post with
Abstract (Original Language): 
Etiolojisi bilinmeyen ve tekrar/ayıcı in/lamatııar olaylarla karakterıze olan Behçet hastalığı, birçok organ sistemini tutan çeşit/i klinik belirtilerle seyreder. Hastalığın mu/tisistemik özelliği nedeniyle değişik tedavi yöntem/eri önerilmekte, diğer birçok tedavi yönteminin de etkinliği halen araştırılmaktadır. Bu yazıda. Behçet hastalığının klinik bulguları, tanı kriterleri ve tedavisindeki son gelişmeler gözden geçirilmektedir. /Turgut Özal Tıp \ lerkezi Dergisi 2(1): ~fi-X5.1995
FULL TEXT (PDF): 
PDF icon arastirmax-behcet-hastaligi-klinik-bulgular-tedavi.pdf
  • 1
78-85
  • Turkish

REFERENCES

References: 

1 Callen JP, Mahl CF. Oculocutaneous manifestations observed in multisystem disorders. Dermatol Clin 1992; 10:709-16.
2. Synderman R. Behçet's disease-Provocative clues. West J Med 1988; 148:438-9.
3. Arbesfeld SJ, Kurban AK. Behçet's disease. J Am Acad Dermatol 1988; 19:767-79.
4. Stratigos AJ, Laskaris G, Stratigos JD. Behçet's disease. Semin Neurol 1992; 12:346-57.
5. Shimizu T. Ehrlıch GE, Inaba G, Hayashi K. Behçet's disease (Behçet's syndrome). Semin Arthritis Rheum 1979, 8:223-60.
6. Michelson JB, Friedlaender MH. Behçet's disease. Int Ophthalmol Clin 1990; 30:271-8.
7. Main DMG, Chamberlain MA. Clinical
83
Oram ve ark.
Behçet 's
disease
: clinical features and treatment
differentiation of oral ulceration in Behçet's disease. Br J Rheumatol 1992; 31:767-70.
8. Nazzaro P. Cutaneous manifestations of Behçet's disease In:Monacelli M, Nazzaro P editors. Behçet disease Basel, Switzerland, S Karger. 1966:15-41.
9. Honma T, Bang D, Saito T, Nakagawa S. Uekı H, Lee S. Infrastructure of lymphocyte-mediated fat-cell lysis in erythema nodosum-like lesions of Behçet's syndrome. Arch Dermatol 1987; 123:1650-4.
10. Honma T, Bang D, Lee S, Saito T. Ultrastructure of endothelial cell necrosis in classical erythema nodosum. Hum Pathol 1993; 24:384-90.
11. Samlaska CP, James WD Superficial thrombophlebitis II. Secondary hypercoagulable states. J Am Acad Dermatol 1990; 23:1-18.
12. Tuzun Y, Akaç M, Yazıcı H. Non-specific skin hyperactivity in Behçet's disease. Haemotologica 65:395-398, 1980.
13Özarmağan
C
, Saylan T, Azizlerli G, Övül C, Aksungur VL. Re-evaluation of the pathergy test in Behçet's disease. Acta Derm Venereol (Stockh) 1991; 71:75-6.
14. Yazıcı H, Chamberlain MA, Tüzün Y, Yurdakul S, Müftüoğlu A. A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease. Ann Rheum Dis 1984; 43:74-5.
15. Michelson JB, Chisari FV. Behçet's disease. Surv Ophthalmol 1982;26:190-203.
16. Chajek T, Fainaru M. Behçet's disease. Report of 41 cases and a review of the literature Medicine 1975; 54:179-96.
17. Mamo GJ. The rate of visual loss in Behçet's disease. Arch Ophthalmol 1970; 84:451-2.
18. Sanders MD, Graham EM. Retinal vasculitis. Postgrad Med J 1988;64:488-96.
19. Allen NB. Miscellaneous vasculitic syndromes including Behçet's disease and central nervous system vasculitis Curr Opin Rheumatol 1993, 5:51-6.
20. Serdaroğlu P, Yazıcı H, Özdemir C, Yurdakul S, Bahar S, Aktin E. Neurologic involvement in Behçet's syndrome. Arch Neurol 1989; 46:265¬269.
21Hirohata S, Tanimoto K, Ito K. Elevation of cerebrospinal fluid interleukin-6 activity in patients with vasculitides and central nervous system involvement Clin Immunol Immunopathol 1993;66:225-9.
22. Sharief MK, Hentges R, Thomas E. Significance
of CSF immunoglobulins in monitoring neurologic disease activity in Behçet's disease Neurology 1991;41:1398-1401
23. Wechsler B, Dell'Isoia B, Vidaıllıet M. Dormont D, Pıette JC, Bletry O, Godeau P MR1 m 31 patients with Behçet's disease and neurological involvement: prospective study with clinical correlation J Neurol Neurosurg Psychiatrv 1993, 56:793-8
24.
Yurdaku
l S, Yazıcı H, Tüzün Y. Pazarlı H. Yalçın B, Altaç M. Özyazgan Y, Tüzimer N, Müftüoğlu A The arthritis of Behçet's disease: a prospective study Ann Rheum Dis 1983; 42:505¬15
25Jawad ASM, Goodwill CJ Behçet's disease with erosive arthritis Ann Rheum Dis 1986. 45:961-2.
26 Shenf A. Stewart P, Mendes DM. The repetitive vascular catastrophes of Behçet's disease: A case report with review of the literature. Ann Vase Surg 1992; 6:85-9.
27. Koç Y, Güllü I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkaııcı F, Akkaya S, Telatar H, Zileli T. Vascular involvement in Behçet's disease. J Rheumatol 1992; 19:402-10.
28. Lie JT. Vascular involvement in Behçet's disease Arterial and venous and vessels of all sizes J Rheumatol 1992; 19:341-3.
29 Jankowski J, Crombıe I, Jankowski R Behçet's syndrome in Scotland. Postgrad Med J 1992; 68:566-70.
30. James DG. 'Silk Route Disease' (Behçet's disease). West J Med 1988; 148:433-7
31Raz I, Okon E. Chajek-Shaul T Pulmonary manifestations in Behçet's syndrome Chest 1989. 95:585-9.
32. Koga T, Yano T, Ichikawa Y, Oizumi K, Mochizuki M Pulmonary infiltrates recovered by FK506 in a patient with Behçet's disease Chest 1993; 104:309-11.
33. Hamuryudan V, Yurdakul S, Kural AR. İnce U. Yazıcı H. Diffuse proliferative glomerulonephritis in Behçet's syndrome. Br J Rheumatol 1991; 30:63-4.
34 Düşen N, Koniçe M, Aral O, Erbengı T, Uysal V, Koçak N, Özdoğan E. Behçet's disease associated with amyloidosis in Turkey and in the world Ann Rheum Dis 1988; 47:157-63.
35. Kırkali Z, Yiğitbaşı O, Şaşmaz R Urological aspects of Behçet's disease. Br .1 Urol 1991; 67:638-9
36. Mizushima Y. Recent research into Behçet's disease in Japan Int J Tiss React X 1988; 59-65.
84
Journal of Turgut Özal Medical Center 2(1):1995
Oram ve ark.
liehçel s
disease
: cluneal features and treatment
3 7 The International Study Group For Behçet's Disease. Evaluation of diagnostic ('classification') criteria in Behçet's disease - ' towards internationally agreed criteria. Br J Rheumatol 1992; 31:299-308.
38 Yazıcı H, Barnes CG. Practical treatment recommendations for pharmacotherapy of Behçet's syndrome. Drugs 1991;42:796-804.
39 Hamuryudan V, Yurdakul S, Serdaroğlu S, Tüzün Y. Rosenkaimer F, Yazıcı H. Topical alpha interferon in the treatment of oral ulcers in Behçet's syndrome: a preliminary report. Clin Exp Rheumatol 1990; 8.51-4.
40 Hamuryudan V. Yurdakul S, Rosenkaimer F, Yazıcı H. Inefficacy of topical alpha interferon in the treatment of oral ulcers of Behçet's syndrome: a randomized, double blind trial. Br J Rheumatol 1991. 30:395-6.
41 Aktulga
A
, Altaç M, Müftüoğlu AU, Özyazgan Y; Pazarlı H A double blind study of colchicine in Behçet's disease. Haematologica 1980; 65:399¬402.
42 Raynor A, Askari AD. Behçet's disease and treatment with colchicine. J Am Acad Dermatol 1980. 2:396-400..
43 Özyazgan Y. Yurdakul S, Yazıcı H, Tüzün B. İşçimen A, Tüzün Y, Aktunç T, Pazarlı H. Hamuryudan V, Müftüoğlu A. Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial. Br J Ophthalmol 1992; 241-3.
44 O'Duffy JD Behçet's syndrome. N Eng J Med 1990.322:326-8.
45 Mamo JG. Azzam SA. Treatment of Behçet's disease with chlorambucil Arch Ophthalmol 1970; 84:446-50.
4<>. Yazıcı H, Pazarlı H, Barnes CG, Tüzün Y. Özyazgan Y, Silman A, Serdaroğlu S. Oğuz V, Yurdakul S. Lovatt GE, Yazıcı B, Somanı S, Müftüoğlu A. A controlled trial of azathioprine in Behçet's syndrome N Eng J Med 1990; 322:281¬5.
47 Nussenblatt RB, Palestine AG, Chan C, Vlochı/.uki M, Yancey K Effectiveness of cyclosporin therapy for Behçet's disease Arthritis Rheum 1985; 28.671-9.
48 BenEzra D, Cohen E, Chajek T, Evaluation of conventional therapy versus cyclosporin A in Behçet's syndrome Transplant Proc 1988; 3:136¬43
49. Faris BM, Foster CS. Behçet's disease. In: Albert DM, Jakobiec FA editors. Principles and Practice of Ophthalmology. Philadelphia: W.B. Saunders, 1994:1018-27.
50. Mochizuki M, Masuda K, Sakane T, Inaba G, Ito K, Kogure M, Sugino N, Usui M, Mizushima Y, Ohno S, Miyanaga Y, Hayasaka S, Ohizumi K. A multicenter clinical open trial of FK 506 in refractory uveitis, including Behçet's disease. Transplant Proc 1991; 23:3343-6.
51. James DG. Behçet's syndrome. N Eng J Med 1979; 301:431-2.
52. Lavery HA, Pinkerton JHM. Successful treatment of Behçet's syndrome with levamisole. Br J Dermatol 1985; 1 13:372-3.
53. Wolf RE, Fudenberg HH, Welch TM, Spitler LE, Ziff M. Treatment of Behçet's syndrome with transfer factor. JAMA 1977; 238:869-71.
54. Sharquie K.E. Suppression of Behçet's disease with dapsone. Br J Dermatol 1984; 110:493-4.
55. Scarlett JA, Kistner ML, Yang LC. Behçet's syndrome- report of a case associated with pericardial effusion and cryoglobulinemia treated with indomethacin. Am J Med 1979; 66:146-8.
56. Şimşek H, Dündar S, Telatar H. Treatment of Behçet's disease with indomethacin. Int J Dermatol 1991, 30:54-7.
57 Resegottı
L
, Pistone M. Acyclovir and Behçet's syndrome. Ann Intern Med 1984; 100:319.
58. Davies UM, Palmer RG, Den man AM. Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: A randomized double-blind trial. Br J Rheumatol 1988; 27:300-2.
59. Durand JM, Kaplanski G, Telle H, Soubeyrand J, Paulo F. Beneficial effects of interferon-2b in Behçet's disease. Arthritis Rheum 1993; 36:1025¬1026.

Thank you for copying data from http://www.arastirmax.com